Skip to main content

Tenofovir Disoproxil Fumarate

NDC 65862-818 · Aurobindo Pharma Limited

Generic nameTenofovir Disoproxil Fumarate
Dosage formTABLET, FILM COATED
RouteORAL
Active ingredient(s)TENOFOVIR DISOPROXIL FUMARATE
Strength150 mg/1
Pharmacologic classHepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS]
Marketing categoryANDA

Packages

65862-818-03 — 3 BLISTER PACK in 1 CARTON (65862-818-03) / 10 TABLET, FILM COATED in 1 BLISTER PACK

65862-818-30 — 30 TABLET, FILM COATED in 1 BOTTLE (65862-818-30)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

61958-0705 — emtricitabine and tenofovir disoproxil fumarate, 61958-1101 — emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate, 61958-1201 — elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate, 62135-466 — TENOFOVIR DISOPROXIL FUMARATE Tablets, 63629-9729 — Tenofovir Disoproxil Fumarate, 64380-714 — tenofovir disoproxil fumarate, 64380-719 — EMTRICITABINE and TENOFOVIR Disoproxil Fumarate, 65862-354 — Emtricitabine and Tenofovir Disoproxil Fumarate, 65862-421 — Tenofovir Disoproxil Fumarate, 65862-497 — Efavirenz, Emtricitabine and Tenofovir Disoproxil Fumarate, 65862-819 — Tenofovir Disoproxil Fumarate, 65862-820 — Tenofovir Disoproxil Fumarate, 67296-2198 — Emtricitabine and tenofovir disoproxil fumarate, 68071-2112 — emtricitabine and tenofovir disoproxil fumarate, 68071-3695 — Emtricitabine and tenofovir disoproxil fumarate, 68071-3831 — Emtricitabine and tenofovir disoproxil fumarate, 68071-3986 — Emtricitabine and Tenofovir Disoproxil Fumarate, 68180-287 — EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE, 69076-105 — Tenofovir Disoproxil Fumarate, 69097-209 — EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE, +69 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels